Leonardi Daniela, Polizzotti Nunziella, Carta Anna, Gelsomino Rossella, Sava Lidia, Vigneri Riccardo, Calaciura Francesca
Endocrinologia-Università di Catania, Ospedale Garibaldi-Nesima, Via Palermo 636, Catania, Italy.
J Clin Endocrinol Metab. 2008 Jul;93(7):2679-85. doi: 10.1210/jc.2007-2612. Epub 2008 Apr 29.
Long-term outcome of thyroid function in children with very short-lasting neonatal hyperthyrotropinemia ("false positive" at neonatal screening) was studied in an observational, prospective study. Thyroid function and morphology were evaluated in 44 "false positive" children up to advanced childhood (8.0 +/- 0.7 yr of age). In these children a high prevalence (50%) of subclinical hypothyroidism in early childhood (2.8 +/- 0.5 yr) had already been described.
At an average of 5.3 yr, subclinical hypothyroidism persisted in 19 of 44 (43.2%) children and, more specifically, in two of three of those who had increased TSH in early childhood. Euthyroidism was present in all cases that were euthyroid in early childhood, although they had TSH and free T(3) values significantly higher than control children with a normal TSH at birth (TSH = 2.6 +/- 0.7 vs. 1.5 +/- 0.6 mU/liter, P < 0.001; free T(3) = 4.9 +/- 0.8 vs. 3.9 +/- 0.9 pmol/liter, P < 0.01). Thyroid morphology alterations were frequent in the group of children with subclinical hypothyroidism. At an average of 8.0 yr, subclinical hypothyroidism persisted in 14 of 44 (31.8%) children. In all other children, TSH and thyroid hormones were confirmed within the normal range.
This prospective longitudinal study confirms that newborns "false positive" at neonatal screening have a high risk to develop persistent subclinical hypothyroidism. The prevalence of hypothyroidism decreases with increasing age, but it is still high (>30%) in late childhood. Even those "false positive" children that maintain euthyroidism in late childhood have an average TSH value that, although within the normal range, is higher than in normal controls, a possible marker of minor congenital thyroid function abnormalities.
在一项观察性前瞻性研究中,对新生儿促甲状腺素血症持续时间极短(新生儿筛查时“假阳性”)的儿童甲状腺功能的长期转归进行了研究。对44名“假阳性”儿童直至童年晚期(8.0±0.7岁)的甲状腺功能和形态进行了评估。在这些儿童中,已发现幼儿期(2.8±0.5岁)亚临床甲状腺功能减退的患病率较高(50%)。
平均5.3岁时,44名儿童中有19名(43.2%)仍存在亚临床甲状腺功能减退,具体而言,幼儿期促甲状腺素升高的儿童中有三分之二仍存在亚临床甲状腺功能减退。幼儿期甲状腺功能正常的所有病例在后期均保持甲状腺功能正常,尽管他们的促甲状腺素和游离T3值显著高于出生时促甲状腺素正常的对照儿童(促甲状腺素=2.6±0.7 vs.1.5±0.6 mU/升,P<0.001;游离T3=4.9±0.8 vs.3.9±0.9 pmol/升,P<0.01)。亚临床甲状腺功能减退组儿童甲状腺形态改变很常见。平均8.0岁时,44名儿童中有14名(31.8%)仍存在亚临床甲状腺功能减退。在所有其他儿童中,促甲状腺素和甲状腺激素均在正常范围内。
这项前瞻性纵向研究证实,新生儿筛查时“假阳性”的新生儿发生持续性亚临床甲状腺功能减退的风险很高。甲状腺功能减退的患病率随年龄增长而降低,但在童年晚期仍很高(>30%)。即使是那些在童年晚期维持甲状腺功能正常的“假阳性”儿童,其促甲状腺素平均水平虽在正常范围内,但仍高于正常对照组,这可能是轻微先天性甲状腺功能异常的一个标志。